Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Benefits of Mobile Apps for Cancer Pain Management: Systematic Review.

Tytuł:
Benefits of Mobile Apps for Cancer Pain Management: Systematic Review.
Autorzy:
Zheng C; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.; School of Pharmacy, Fujian Medical University, Fuzhou, China.
Chen X; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Weng L; Department of Pharmacy, Xiamen Maternity and Child Care Hospital, Xiamen, China.
Guo L; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Xu H; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Lin M; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Xue Y; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Lin X; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Yang A; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Yu L; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Xue Z; Department of Pharmacy, Fuqing City Hospital, Fuzhou, China.
Yang J; School of Pharmacy, Fujian Medical University, Fuzhou, China.; Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China.
Źródło:
JMIR mHealth and uHealth [JMIR Mhealth Uhealth] 2020 Jan 23; Vol. 8 (1), pp. e17055. Date of Electronic Publication: 2020 Jan 23.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
Język:
English
Imprint Name(s):
Original Publication: Toronto: JMIR Publications Inc., [2013]-
MeSH Terms:
Cancer Pain*/therapy
Cell Phone*
Mobile Applications*
Neoplasms*/complications
Neoplasms*/therapy
Humans ; Quality of Life
References:
Support Care Cancer. 2018 Nov;26(11):3721-3728. (PMID: 29732483)
Breast Cancer Res Treat. 2017 Feb;161(3):443-452. (PMID: 27933450)
JMIR Mhealth Uhealth. 2017 Jul 25;5(7):e108. (PMID: 28743681)
JAMA. 2010 Jul 14;304(2):163-71. (PMID: 20628129)
J Telemed Telecare. 2011;17(6):308-12. (PMID: 21844177)
Pediatr Blood Cancer. 2017 Oct;64(10):. (PMID: 28423223)
J Sports Med Phys Fitness. 2017 Jan-Feb;57(1-2):154-160. (PMID: 26558836)
JMIR Mhealth Uhealth. 2019 Feb 04;7(2):e11094. (PMID: 30714943)
CA Cancer J Clin. 2017 May 6;67(3):194-232. (PMID: 28436999)
JMIR Mhealth Uhealth. 2015 Mar 27;3(1):e31. (PMID: 25830810)
Psychooncology. 2018 Feb;27(2):524-531. (PMID: 28665541)
J Clin Oncol. 2012 Apr 20;30(12):1296-303. (PMID: 22412149)
Support Care Cancer. 2017 Jul;25(7):2195-2204. (PMID: 28236145)
Support Care Cancer. 2018 Feb;26(2):635-642. (PMID: 28929433)
JMIR Mhealth Uhealth. 2017 Dec 04;5(12):e187. (PMID: 29203459)
JMIR Mhealth Uhealth. 2019 Feb 12;7(2):e13080. (PMID: 30747715)
Br J Pain. 2016 Aug;10(3):135-40. (PMID: 27583140)
JMIR Res Protoc. 2019 Jun 03;8(6):e12940. (PMID: 31162132)
JMIR Mhealth Uhealth. 2019 Feb 11;7(2):e10930. (PMID: 30741644)
Pain Res Treat. 2016;2016:2473629. (PMID: 27891252)
Cochrane Database Syst Rev. 2016 Aug 15;(8):CD006911. (PMID: 27524661)
JMIR Mhealth Uhealth. 2019 May 29;7(5):e12542. (PMID: 31144672)
Pain. 2015 Dec;156(12):2607-15. (PMID: 26580680)
J Clin Rheumatol. 2019 Apr;25(3):133-141. (PMID: 29933327)
J Pain Symptom Manage. 2015 Oct;50(4):553-8. (PMID: 26025279)
JMIR Mhealth Uhealth. 2018 Oct 22;6(10):e11231. (PMID: 30348633)
Support Care Cancer. 2018 Feb;26(2):337-351. (PMID: 28921391)
Pain Manag. 2019 Jan 1;9(1):63-79. (PMID: 30516438)
J Med Internet Res. 2013 Mar 08;15(3):e51. (PMID: 23475457)
J Med Internet Res. 2017 Nov 10;19(11):e385. (PMID: 29127076)
PLoS One. 2014 Jul 07;9(7):e101312. (PMID: 24999983)
Support Care Cancer. 2019 May;27(5):1775-1781. (PMID: 30146666)
JMIR Mhealth Uhealth. 2017 Oct 23;5(10):e162. (PMID: 29061558)
J Psychosoc Oncol. 2019 May-Jun;37(3):335-349. (PMID: 30585762)
Br J Pain. 2014 Nov;8(4):139-53. (PMID: 26516548)
Clin J Pain. 2015 Jun;31(6):557-63. (PMID: 25370138)
Reg Anesth Pain Med. 2017 Jul/Aug;42(4):488-498. (PMID: 28570436)
J Cancer Surviv. 2019 Feb;13(1):97-107. (PMID: 30635865)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
JMIR Mhealth Uhealth. 2017 Mar 01;5(3):e4. (PMID: 28249834)
JMIR Mhealth Uhealth. 2019 Jan 15;7(1):e12297. (PMID: 30664494)
Clin J Pain. 2015 Jun;31(6):536-47. (PMID: 25503599)
Contributed Indexing:
Keywords: cancer pain; instant messaging; meta-analysis; mobile apps
Entry Date(s):
Date Created: 20200204 Date Completed: 20210401 Latest Revision: 20210401
Update Code:
20240105
PubMed Central ID:
PMC7005688
DOI:
10.2196/17055
PMID:
32012088
Czasopismo naukowe
Background: Pain ratings reported by patients with cancer continue to increase, and numerous computer and phone apps for managing cancer-related pain have been developed recently; however, whether these apps effectively alleviate patients' pain remains unknown.
Objective: This study aimed to comprehensively evaluate the role of mobile apps in the management of cancer pain.
Methods: Literature on the use of apps for cancer pain management and interventions, published before August 2019, was retrieved from the following databases: MEDLINE, Embase, Cochrane, CINAHL, Scopus, and PsycINFO. The effects of apps on cancer pain were evaluated using RevMan5.3 software, and the rates of adverse drug reactions were analyzed using the R Statistical Software Package 3.5.3.
Results: A total of 13 studies were selected for the analysis: 5 randomized controlled trials (RCTs), 4 before-after studies, 2 single-arm trials, 1 prospective cohort study, and 1 prospective descriptive study. The 5 RCTs reported data for 487 patients (240 patients in the intervention group and 247 patients in the control group), and the remaining studies reported data for 428 patients. We conducted a meta-analysis of the RCTs. According to the meta-analysis, apps can significantly reduce pain scores (mean difference [MD]=-0.50, 95% CI -0.94 to -0.07, I 2 =62%, P=.02). We then used apps that have an instant messaging module for subgroup analysis; these apps significantly reduced patients' pain scores (MD=-0.67, 95% CI -1.06 to -0.28, I 2 =57%, P<.01). Patients using apps without an instant messaging module did not see a reduction in the pain score (MD=0.30, 95% CI -1.31 to 1.92, I 2 =70%, P=.71). Overall, patients were highly satisfied with using apps. Other outcomes, such as pain catastrophizing or quality of life, demonstrated greater improvement in patients using apps with instant messaging modules compared with patients not using an app.
Conclusions: The use of apps with instant messaging modules is associated with reduced pain scores in patients with cancer-related pain, and patient acceptance of these apps is high. Apps without instant messaging modules are associated with relatively higher pain scores. The presence of an instant messaging module may be a key factor affecting the effect of an app on cancer pain.
(©Caiyun Zheng, Xu Chen, Lizhu Weng, Ling Guo, Haiting Xu, Meimei Lin, Yan Xue, Xiuqin Lin, Aiqin Yang, Lili Yu, Zenggui Xue, Jing Yang. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 23.01.2020.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies